NASDAQ : MEDS
DataMEDS AI, Inc. — Key statistics
Healthcare · Pharmaceutical Retailers · United States
Last price 1.92 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 5.88M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 5.60M |
| Enterprise Value | 35.77M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 19, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 3.06M |
| Shares Outstanding | 3.06M |
| Shares Change (YoY) | +93.15% |
| Shares Change (QoQ) | +23.05% |
| Owned by Insiders (%) | 45.93% |
| Owned by Institutions (%) | 3.38% |
| Float | 1.46M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.70 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 4.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.14 |
| Quick Ratio | 0.09 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.72 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -82.93% |
| Return on Invested Capital (ROIC) | -186.56% |
| Return on Capital Employed (ROCE) | 867.20% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.18 |
| Inventory Turnover | 2.90 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | -94.77% |
| 50-Day Moving Average | 2.48 |
| 200-Day Moving Average | 5.77 |
| Relative Strength Index (RSI) | 37.79 |
| Average Volume (20 Days) | 2,355,202 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 476,294 |
| Short Previous Month | 525,081 |
| Short % of Shares Out | 15.56% |
| Short % of Float | 32.72% |
| Short Ratio (days to cover) | 0.03 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 8.02M |
| Gross Profit | -7.27M |
| Operating Income | -57.71M |
| Pretax Income | -88.28M |
| Net Income | -88.28M |
| EBITDA | -55.39M |
| EBIT | -57.71M |
| Loss Per Share | -$43.73 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 2.46M |
| Total Debt | 32.62M |
| Net Cash | -30.17M |
| Net Cash Per Share | -$9.85 |
| Equity (Book Value) | -19.50M |
| Book Value Per Share | -6.88 |
| Working Capital | -33.78M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -13.74M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2.32M |
| Net Borrowing | 8.35M |
| Free Cash Flow | -17.16M |
| FCF Per Share | -$5.61 |
Margins
| Measure | Value |
|---|
| Gross Margin | -90.64% |
| Operating Margin | -719.27% |
| Pretax Margin | -1,100.30% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -93.15% |
| Shareholder Yield | -93.15% |
| Earnings Yield | -2,389.40% |
| FCF Yield | -306.29% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 18.40% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 26, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -12.18 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |